Stay updated on PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.

Latest updates to the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page
- Check2 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check9 days agoChange DetectedThe ClinicalTrials.gov interface revision displayed in the footer changes from v3.7.0 to v3.7.1; the study record history remains unchanged.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedA new software Revision: v3.7.0 entry was added to the record history and the previous Revision: v3.6.6 entry was removed. This indicates an update to the revision-tracking system used on the page, rather than a change to study data.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision v3.6.6 was added to the study record history. The previous revision v3.6.5 was removed from the history.SummaryDifference0.1%

- Check58 days agoChange DetectedNew history entry added for version 14 (Study Status) on 2026-07-31, with an additional date entry on 2026-08-24. An older entry dated 2026-01-08 was removed from the history.SummaryDifference0.4%

- Check72 days agoChange DetectedA new revision entry 'Revision: v3.6.5' was added to the study record history, and the previous 'Revision: v3.6.4' entry was removed.SummaryDifference0.1%

Stay in the know with updates to PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.